Publications by authors named "I Cipullo"

Objective: evaluate the efficacy and tolerability of PureCyTonin against hot flashes (HF) in breast cancer survivors (BCS).

Methods: a prospective, multicenter, randomized, double-blind placebo-controlled trial was conducted in Italy.

Interventions: administration of PureCyTonin or placebo, for 3 months.

View Article and Find Full Text PDF

Background: Knot security of half-knot (H) sequences varies with rotation, but half-knots risk destabilisation.

Objectives: To investigate the rotation of half-hitch (S) sequences on knot security.

Materials And Methods: The loop and knot security of symmetrical and asymmetrical sliding and blocking half-hitch sequences was measured using a tensiometer.

View Article and Find Full Text PDF

The loop and knot securities of two polyfilament and two monofilament sutures of four diameters (3.0, 2.0, 0, 1) were evaluated with a tensiometer for four four-throw knots, known to be secure with a 2.

View Article and Find Full Text PDF

Background: Adjuvant endocrine therapy (AET) reduces breast cancer recurrence and mortality of women with hormone-receptor-positive tumors, but poor adherence remains a significant problem. The aim of this study was to analyze AET side effects and their impact on adherence to treatment.

Methods: A total of 373 breast cancer patients treated with AET filled out a specific questionnaire during their follow up visits at the Breast Unit of our Centre.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the effectiveness and tolerability of a "sandwich" treatment schedule that combines chemotherapy (CT) and radiotherapy (RT) for patients with intermediate-high- and high-risk endometrial cancer (EC).
  • Conducted in Torino, Italy, the retrospective study analyzed clinical data from 118 patients over nearly two decades, assessing treatment compliance, toxicities, and survival outcomes.
  • Results showed that the "sandwich" schedule achieved a notable disease-free survival rate of 77.6% and overall survival of 54%, with low levels of severe toxicities reported among participants.
View Article and Find Full Text PDF